ORIC Pharmaceuticals

company

Number of Lead Investors

Number of Investors

ORIC Pharmaceuticals is funded by 21 investors. Pfizer and ArrowMark Partners are the most recent investors.

Investor Name	Lead Investor	Funding Round
Pfizer	Yes	Post-IPO Equity
ArrowMark Partners	Yes	Series D
Invus	Yes	Series D
Casdin Capital	-	Series D
City Hill Ventures	-	Series D
Correlation Ventures	-	Series D
EcoR1 Capital	-	Series D
Fidelity Management and Research Company	-	Series D
Foresite Capital	-	Series D
Hartford HealthCare Endowment	-	Series D
Irving Investors	-	Series D
Kravis Investment Partners	-	Series D
Memorial Sloan - Kettering Cancer Center	-	Series D
OrbiMed	-	Series D
Taiho Ventures	-	Series D
The Column Group	-	Series D
Topspin Partners	-	Series D
NS Investment	-	Series C
Topspin Fund	-	Series C
Trinitas Capital	-	Series C
Kohlberg Kravis Roberts	-	Series B